Ramez Nassef Eskander, Michael Sill, Lindsey Beffa, Richard G. Moore, Joanie Mayer Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Henrique Cantuaria, Eugenia Girda, Cara Amanda Mathews, Juraj Kavecansky, Charles A. Leath, Lilian Tran Gien, Emily Hinchcliff, Shashikant B. Lele, Lisa Michelle Landrum, Floor Jenniskens Backes, Matthew A. Powell, Carol Aghajanian. "Updated overall survival analysis and examination of subsequent therapy in endometrial cancer (EC) patients (pts) treated with pembrolizumab plus carboplatin/paclitaxel (CP) as compared to CP plus placebo (PBO) in the NRG-GY018 trial.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.5502